Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.48 |
| ▸ | ITPR3 | Q14573 | 4/20 | 0.47 |
| ▸ | ITPR2 | Q14571 | 1/20 | 0.47 |
| ▸ | ITPR1 | Q14643 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5381912 | 1.00 | SMPD1 (0.48) | SMPD1ITPR3ITPR2ITPR1 | |
| SCHEMBL4595256 | 1.00 | SMPD1 (0.48) | SMPD1ITPR3ITPR2ITPR1 | |
| SCHEMBL7796118 | 1.00 | SMPD1 (0.48) | SMPD1ITPR3ITPR2ITPR1 | |
| SCHEMBL4596697 | 1.00 | SMPD1 (0.48) | SMPD1ITPR3ITPR2ITPR1 | |
| SCHEMBL30237668 | 0.93 | SMPD1 (0.54) | SMPD1ITPR3ITPR2ITPR1 | |
| SCHEMBL7798872 | 0.87 | SMPD1 (0.50) | SMPD1ITPR3ITPR2ITPR1 | |
| SCHEMBL4191662 | 0.87 | SMPD1 (0.50) | SMPD1ITPR3ITPR2ITPR1 | |
| SCHEMBL4442196 | 0.87 | SMPD1 (0.50) | SMPD1ITPR3ITPR2ITPR1 | |
| SCHEMBL31076318 | 0.86 | ADORA1 (0.43) | SMPD1ITPR3ITPR2ITPR1 | |
| SCHEMBL31076275 | 0.86 | ADORA1 (0.43) | SMPD1ITPR3ITPR2ITPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7309567-B1 | Method for reducing fluorescence quenching in bioassays | CIS BIO INTERNATIONAL (FR) | 2007-12-18 | — | — | US | disclosed |
| US-20050239073-A1 | Fluorescent entity comprising a fluorophore covalently attached to at least one oligonucleotide and comprising at least one functional group, and uses thereof | CIS BIO INTERNATIONAL (FR) | 2005-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239073-A1 | Fluorescent entity comprising a fluorophore covalently attached to at least one oligonucleotide and comprising at least one functional group, and uses thereof | INCENP, SLCO2A1, CARS1 | SMPD1 3569/4885ITPR3 763/4885ITPR2 1271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.